Security key
640671400
NEPHROS INC - Common Stock - $0.001 par value (NEPH)
CUSIP: 640671400
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock - $0.001 par value
- Shares outstanding
- 10,630,964
- Total 13F shares
- 4,339,484
- Share change
- +49,546
- Total reported value
- $3,949,000
- Price per share
- $0.91
- Number of holders
- 17
- Value change
- +$17,380
- Number of buys
- 8
- Number of sells
- 4
Report period
Q3 2022
Institutions
17
Top holders
10
NEPH full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
NEPHROS INC SEC filings
NEPHROS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640671400
Recent filing periods:
Top shareholders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
13F
|
Company |
34%
|
3,655,111
|
$174,670,000 | — | 30 Jun 2022 | |
| BARD ASSOCIATES INC |
13F
|
Company |
2.5%
|
263,754
|
$404,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
122,678
|
$188,000 | — | 30 Jun 2022 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.52%
|
55,710
|
$85,000 | — | 30 Jun 2022 | |
| Cowen Prime Advisors LLC |
13F
|
Company |
0.4%
|
42,500
|
$65,000 | — | 30 Jun 2022 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.34%
|
36,249
|
$55,000 | — | 30 Jun 2022 | |
| ELKHORN PARTNERS LIMITED PARTNERSHIP |
13F
|
Company |
0.32%
|
34,000
|
$52,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
18,254
|
$28,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
15,698
|
$24,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.11%
|
12,095
|
$19,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
11,359
|
$17,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.09%
|
9,304
|
$14,000 | — | 30 Jun 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
4,569
|
$7,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
4,131
|
$6,000 | — | 30 Jun 2022 | |
| Total Clarity Wealth Management, Inc. |
13F
|
Company |
0.02%
|
1,657
|
$3,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
515
|
$1,000 | — | 30 Jun 2022 | |
| Daron Evans |
3/4/5
|
CEO Specialty Renal Products |
—
mixed-class rows
|
179,718
mixed-class rows
|
$351,795 | — | 24 May 2021 | |
| Andrew Astor Power |
3/4/5
|
President, CEO & CFO, Director |
—
mixed-class rows
|
131,385
mixed-class rows
|
$204,342 | — | 05 Mar 2022 | |
| Wesley S. Lobo |
3/4/5
|
Chief Marketing Officer |
—
mixed-class rows
|
206,714
mixed-class rows
|
$77,461 | — | 16 Feb 2022 |
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q3 2022
As of 30 Sep 2022,
NEPHROS INC - Common Stock - $0.001 par value (NEPH) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,339,484 shares.
The largest 10 holders included
WEXFORD CAPITAL LP, BARD ASSOCIATES INC, VANGUARD GROUP INC, HighTower Advisors, LLC, ELKHORN PARTNERS LIMITED PARTNERSHIP, BLAIR WILLIAM & CO/IL, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, STATE STREET CORP, and MORGAN STANLEY.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
15
Q3 2022 holders
17
Holder diff
2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.